GlassScriptPhysician profile
Alexandra Tilt
NPI 1609261924
$13,039.16
in general payments reported to CMS, 2019-2025
18 companies · $4,878 in 2025
The $4,878 reported for 2025 was more than what 92% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2021: $1,609 · 2022: $309 · 2023: $839 · 2024: $5,172 · 2025: $4,878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,148 · Travel and Lodging: $2,829 · Long Term Medical Supply Or Device Loan: $2,711 · Honoraria: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,147.86 |
| Travel and Lodging | $2,829.04 |
| Long Term Medical Supply Or Device Loan | $2,711.27 |
| Honoraria | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $2,772.49 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Integra Lifesciences Corporation | $2,750.66 | 2023-2025 | Durasorb Monofilament Mesh, Acell, Integra |
| Allergan, INC. | $2,113.79 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $1,865.20 | 2023-2025 | |
| Rti Surgical, INC | $1,419.33 | 2023-2024 | |
| Abbvie INC. | $773.76 | 2023-2025 | Botox, Alloderm |
| Mentor Worldwide LLC | $588.52 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Lifenet Health | $315.46 | 2024-2025 | Theragenesis Wound Matrix |
| Smith+Nephew, INC. | $117.63 | 2022-2025 | Collagenase Santyl, Stravix |
| Convatec INC. | $95.31 | 2024-2025 | |
| Davol INC. | $52.07 | 2024-2025 | Phasix Mesh |
| Organogenesis INC. | $38.31 | 2024-2025 | Cygnus Dual |
| Kerecis Limited | $31.46 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Solventum Corporation | $31.22 | 2024 | 3m Medipore, Activ.A.C., Snap |
| Innovation Technologies INC | $20.50 | 2025 | Irrisept |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $19.64 | 2024 | |
| Biocomposites INC | $18.78 | 2025 | Stimulan |
| Motiva USA, LLC | $15.03 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Tilt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.